Pantomylan (Pantoprazole Sodium Sesquihydrate)

Pantoprazole, the active ingredient in Pantomylan, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid production and is indicated for conditions such as gastro‑oesophageal reflux disease, ulcer disease and hypersecretory disorders.\n\nGNH India supplies Pantomylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole, a proton pump inhibitor, is used to reduce gastric acid secretion in several acid‑related conditions.\n\n- Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and esophageal irritation.\n- Erosive oesophagitis: promotes healing of acid‑induced esophageal lesions.\n- Zollinger‑Ellison syndrome: controls excessive gastric acid production.\n- Peptic ulcer disease: facilitates ulcer healing and prevents recurrence.

Adverse reactions may occur with pantoprazole use.\n\nCommon Side Effects:\n- Headache: mild to moderate pain often transient.\n- Diarrhoea: loose stools, usually self‑limiting.\n- Abdominal pain: discomfort in the stomach area.\n- Nausea: feeling of sickness without vomiting.\n- Flatulence: increased intestinal gas.\n- Constipation: difficulty passing stools.\n\nSerious or Rare Side Effects:\n- Severe allergic reactions: rash, swelling, anaphylaxis.\n- Clostridioides difficile infection: severe colitis.\n- Hypomagnesemia: low magnesium levels with prolonged use.\n- Liver enzyme elevation: increased ALT/AST.\n- Pancreatitis: inflammation of the pancreas.\n- Interstitial nephritis: kidney inflammation.

When prescribing pantoprazole, consider the following precautions.\n\n- Renal function assessment: adjust use in severe renal impairment.\n- Hepatic impairment: use with caution in patients with liver disease.\n- Magnesium monitoring: check serum magnesium during long‑term therapy.\n- Discontinuation: avoid abrupt stop to prevent rebound acid hypersecretion.\n- Pregnancy and lactation: use only if benefit outweighs potential risk.\n- Store at room temperature: keep in the original packaging, protect from moisture and heat.

Pantoprazole may interact with other medicines; awareness of interaction severity is essential.\n\nMajor Interactions (Avoid):\n- Atazanavir, nelfinavir, rilpivirine: reduced absorption of these antivirals.\n- Clopidogrel: decreased activation, reducing antiplatelet effect.\n- Methotrexate: increased serum levels, risk of toxicity.\n\nModerate Interactions (Monitor Closely):\n- Warfarin: possible increase in INR, monitor coagulation.\n- Digoxin: elevated plasma concentrations, watch for toxicity.\n- HIV protease inhibitors (e.g., ritonavir): altered pharmacokinetics, adjust dosing.\n- Fluconazole: increased pantoprazole exposure, monitor for side effects.